| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Common Stock | Award | $56,500 | +32,471 | +184% | $1.74 | 50,076 | 13 Mar 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Restricted Stock Units | Award | $0 | +71,839 | $0.000000 | 71,839 | 13 Mar 2025 | Common Stock | 71,839 | Direct | F2, F3 | ||
| transaction | PGEN | Option to Purchase Common Stock (Right to Buy) | Award | $0 | +83,517 | $0.000000 | 83,517 | 13 Mar 2025 | Common Stock | 83,517 | $1.74 | Direct |
| Id | Content |
|---|---|
| F1 | The shares were issued to the reporting person in lieu of an annual retainer of $56,500. |
| F2 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| F3 | The RSUs vest in full on March 13, 2026. |